×
About 449 results

ALLMedicine Acute Bronchospasm Center

Research & Reviews  37 results

Theophylline Level 
https://emedicine.medscape.com/article/2090395-overview

Feb 9th, 2020 - Reference Range Theophylline is a methylxanthine, a class of molecule similar to the xanthines caffeine and theobromine found in a normal diet. [1, 2] It has a half-life of 8 hours in a healthy person but decreases to 4-5 hours in people who smoke...

Theophylline Level 
https://emedicine.medscape.com/article/2090395-print

Feb 9th, 2020 - Theophylline is a methylxanthine, a class of molecule similar to the xanthines caffeine and theobromine found in a normal diet.[1, 2] It has a half-life of 8 hours in a healthy person but decreases to 4-5 hours in people who smoke.[3] In the blood...

Tissue traction microscopy to quantify muscle contraction within precision-cut lung sli...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7052683
American Journal of Physiology. Lung Cellular and Molecular Physiology; Ram-Mohan S, Bai Y et. al.

Nov 27th, 2019 - In asthma, acute bronchospasm is driven by contractile forces of airway smooth muscle (ASM). These forces can be imaged in the cultured ASM cell or assessed in the muscle strip and the tracheal/bronchial ring, but in each case, the ASM is studied ...

FDA approves benralizumab autoinjector for eosinophilic asthma
https://www.mdedge.com/pulmonary-health-hub/article/209478/asthma/fda-approves-benralizumab-autoinjector-eosinophilic?channel=94
Christopher Palmer

Oct 4th, 2019 - The Food and Drug Administration has approved a prefilled, single-use autoinjector of benralizumab (Fasenra) for self-administration in adults with eosinophilic asthma, according to a press release from AstraZeneca. Benralizumab is already approve.

Incidence of acute bronchospasm during systemic adenosine administration for coronary a...
https://doi.org/10.4997/JRCPE.2019.307
The Journal of the Royal College of Physicians of Edinburgh; Morrow A, Ford TJ et. al.

Sep 9th, 2019 - Adenosine is frequently used during coronary angiography to induce hyperaemia and allow operators to perform quantitative measurements of lesion severity. Acute bronchospasm is a recognised side effect relating to the activation of 'off target' A2...

see more →

Guidelines  1 results

NUCALA (mepolizumab) For Severe Eosinophilic Asthma
https://gskpro.com/en-us/products/nucala

NUCALA is indicated for the add-on maintenance treatment of patients 12 years and older with severe asthma with an eosinophilic phenotype. NUCALA is not indicated for the relief of acute bronchospasm or status asthmaticus.

see more →

Drugs  175 results see all →

Clinicaltrials.gov  227 results

Budesonide inhalation suspension - budesonide inhalant-Cipla USA Inc.
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=c52c5382-1400-44b9-95be-a30e1cf706da

May 28th, 2020 - Budesonide inhalation suspension is an inhaled corticosteroid indicated for: • Maintenance treatment of asthma and as prophylactic therapy in children 12 months to 8 years of age (1) Limitations of Use: Not indicated for the relief of acute bronch...

Flovent hfa - fluticasone propionate aerosol, metered-Preferred Pharmaceuticals Inc.
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=7117b2bb-fcd1-43b8-a78d-3f7f9ceefaa0

May 20th, 2020 - FLOVENT HFA is indicated for the maintenance treatment of asthma as prophylactic therapy in patients aged 4 years and older. Important Limitation of Use Flovent HFA is not indicated for the relief of acute bronchospasm. FLOVENT HFA is an inhaled c...

Fluticasone propionate and salmeterol diskus - fluticasone propionate and salmeterol powder-A-S Medication Solutions
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=9e237635-6975-4930-9ce1-051d9e3bf615

Apr 26th, 2020 - Fluticasone Propionate/Salmeterol DISKUS is a combination product containing a corticosteroid and a long-acting beta2-adrenergic agonist (LABA) indicated for: •Twice-daily treatment of asthma in patients aged 4 years and older. (1.1) •Maintenance ...

Advair diskus - fluticasone propionate and salmeterol powder-REMEDYREPACK INC.
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=d18ddede-c300-4ba1-8b19-055181eeed28

Apr 13th, 2020 - ADVAIR DISKUS is a combination product containing a corticosteroid and a long-acting beta 2-adrenergic agonist (LABA) indicated for: Twice-daily treatment of asthma in patients aged 4 years and older. ( 1.1) Maintenance treatment of airflow obstru...

Budesonide inhalation suspension - budesonide inhalant-Preferred Pharmaceuticals Inc.
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=dcb35488-23c5-4e7b-ab86-8406cf855748

Apr 6th, 2020 - Budesonide inhalation suspension is an inhaled corticosteroid indicated for: • Maintenance treatment of asthma and as prophylactic therapy in children 12 months to 8 years of age (1) Limitations of Use: Not indicated for the relief of acute bronch...

see more →

News  9 results

FDA approves benralizumab autoinjector for eosinophilic asthma
https://www.mdedge.com/pulmonary-health-hub/article/209478/asthma/fda-approves-benralizumab-autoinjector-eosinophilic?channel=94
Christopher Palmer

Oct 4th, 2019 - The Food and Drug Administration has approved a prefilled, single-use autoinjector of benralizumab (Fasenra) for self-administration in adults with eosinophilic asthma, according to a press release from AstraZeneca. Benralizumab is already approve.

FDA Approves Mepolizumab (Nucala) for Severe Asthma
https://www.medscape.com/viewarticle/853957

Nov 3rd, 2015 - The US Food and Drug Administration (FDA) approved mepolizumab (Nucala, GlaxoSmithKline) for use in combination with other medications for maintenance treatment of severe asthma in patients aged 12 years or older and with an eosinophilic phenotype...

FDA Approves Long-Acting COPD Inhaler
https://www.medpagetoday.com/pulmonology/smokingcopd/47038

Aug 1st, 2014 - The FDA approved another once-daily bronchodilator, olodaterol (Striverdi Respimat), for maintenance treatment of chronic obstructive pulmonary disease (COPD). Approved indications for the long-acting beta-adrenergic agonist (LABA) drug included l...

How Does Levalbuterol (Xopenex®) Compare With Albuterol?
https://www.medscape.com/viewarticle/719008

Mar 29th, 2010 - Question When is levalbuterol (Xopenex®) preferred over albuterol? Response from Darrell Hulisz, PharmD Associate Professor, Department of Family Medicine, Case Western Reserve University, Cleveland, Ohio; Clinical Pharmacist, University Hospitals...

Inhaled beta-agonists increase risk of cardiac arrest in asthmatics
https://www.medscape.com/viewarticle/785842

Jan 5th, 2003 - Mon, 06 Jan 2003 14:15:00 Seattle, WA - Inhaled beta-agonists, used to treat acute bronchospasm in patients with asthma or chronic obstructive pulmonary disease (COPD), can increase the risk of primary cardiac arrest, at least in asthmatic patient...

see more →